Clinical Development Pharmaceutical Companies Protein Production Therapies 
Drug Discovery World
MARCH 6, 2024
Guiding neurological drug discovery and development to success The 20 years since the Human Genome Project has seen transformational advances in the molecular understanding of cancers and rare genetic diseases, leading to genetically informed, personalised selection of therapies and massively improved outcomes for many patients.
Codon
MARCH 24, 2024
Between the technical uncertainty and the horrendous PR, pharmaceutical companies had little interest in adopting molecular farming technologies. Once approved, patent-protected drugs are the highest-margin physical products on the planet—even with the high price of bioreactors. The real cost is clinical development.
Expert insights. Personalized for you.
162 
Let's personalize your content